{"parse":{"title":"Prescription costs","pageid":18665076,"revid":854436323,"text":{"*":"<div class=\"mw-parser-output\"><p>\n<b>Prescription costs</b> are a common <a href=\"/wiki/Health_care_cost\" class=\"mw-redirect\" title=\"Health care cost\">health care cost</a> for many people and also the source of economic hardship for some.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Definition\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Definition</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Drug_pricing_factors\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Drug pricing factors</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Marketing_expenses\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Marketing expenses</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Research_and_development\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Research and development</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-5\"><a href=\"#Discovery\"><span class=\"tocnumber\">2.2.1</span> <span class=\"toctext\">Discovery</span></a></li>\n<li class=\"toclevel-3 tocsection-6\"><a href=\"#Trials\"><span class=\"tocnumber\">2.2.2</span> <span class=\"toctext\">Trials</span></a></li>\n<li class=\"toclevel-3 tocsection-7\"><a href=\"#Failed_drugs\"><span class=\"tocnumber\">2.2.3</span> <span class=\"toctext\">Failed drugs</span></a></li>\n<li class=\"toclevel-3 tocsection-8\"><a href=\"#Relationship\"><span class=\"tocnumber\">2.2.4</span> <span class=\"toctext\">Relationship</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Stakeholders\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Stakeholders</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Public_policy\"><span class=\"tocnumber\">2.4</span> <span class=\"toctext\">Public policy</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Effect_of_cost_on_consumers\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Effect of cost on consumers</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#By_region\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">By region</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#United_States\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">United States</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#United_Kingdom\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">United Kingdom</span></a></li>\n<li class=\"toclevel-2 tocsection-15\"><a href=\"#Developing_world\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Developing world</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#Further_information\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Further information</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Definition\">Definition</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=1\" title=\"Edit section: Definition\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Prescription costs is a vague term: It can either mean the entire cost of a prescribed drug or health aide (a nebulizer, a wheelchair, etc.) - or just the out-of-pocket prescription cost for those with health insurance, since some of it may be paid by a third party.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup> Prescription costs are a regular health care cost for the sick and may mean economic hardship for the underprivileged.<sup id=\"cite_ref-NYT-20151219_1-0\" class=\"reference\"><a href=\"#cite_note-NYT-20151219-1\">&#91;1&#93;</a></sup>\nPrescription costs in the U.S. include deductibles, co-payments, and upper limits in coverage.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup>\n</p><p>As of 2017, prescription costs range from just more than 15% in high income countries to 25% in lower-middle income countries and low income countries.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>418</span></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Drug_pricing_factors\">Drug pricing factors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=2\" title=\"Edit section: Drug pricing factors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"wikitable\" style=\"float: right; margin-left:15px; text-align:center\">\n<caption>Drug costs in different countries<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</caption>\n<tbody><tr>\n<th>Drug\n</th>\n<th>US\n</th>\n<th>Canada\n</th>\n<th>UK\n</th>\n<th>Spain\n</th>\n<th>Netherlands\n</th></tr>\n<tr>\n<td><a href=\"/wiki/Enbrel\" class=\"mw-redirect\" title=\"Enbrel\">Enbrel</a>\n</td>\n<td>$2,225\n</td>\n<td>$1,646\n</td>\n<td>$1,117\n</td>\n<td>$1,386\n</td>\n<td>$1,509\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Celebrex\" class=\"mw-redirect\" title=\"Celebrex\">Celebrex</a>\n</td>\n<td>$225\n</td>\n<td>$51\n</td>\n<td>$112\n</td>\n<td>$164\n</td>\n<td>$112\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Copaxone\" class=\"mw-redirect\" title=\"Copaxone\">Copaxone</a>\n</td>\n<td>$3,903\n</td>\n<td>$1,400\n</td>\n<td>$862\n</td>\n<td>$1,191\n</td>\n<td>$1,190\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Cymbalta\" class=\"mw-redirect\" title=\"Cymbalta\">Cymbalta</a>\n</td>\n<td>$194\n</td>\n<td>$110\n</td>\n<td>$46\n</td>\n<td>$71\n</td>\n<td>$52\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Humira\" class=\"mw-redirect\" title=\"Humira\">Humira</a>\n</td>\n<td>$2,246\n</td>\n<td>$1,950\n</td>\n<td>$1,102\n</td>\n<td>$1,498\n</td>\n<td>$1,498\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Nexium\" class=\"mw-redirect\" title=\"Nexium\">Nexium</a>\n</td>\n<td>$215\n</td>\n<td>$30\n</td>\n<td>$42\n</td>\n<td>$58\n</td>\n<td>$23\n</td></tr></tbody></table>\n<p>Pricing any pharmaceutical drug for sale to the general public is daunting. Per Forbes, setting a high ceiling price for a new drug could be problematic as physicians could shy away from prescribing the drug, because the cost could be too great for the benefit.<sup id=\"cite_ref-:1_4-0\" class=\"reference\"><a href=\"#cite_note-:1-4\">&#91;4&#93;</a></sup> Setting too low of a price could imply inferiority, that the drug is too \"weak\" for the market.<sup id=\"cite_ref-:1_4-1\" class=\"reference\"><a href=\"#cite_note-:1-4\">&#91;4&#93;</a></sup> There are many different pricing strategies and factors that go into the research and evaluation of a future drug\u2019s price with whole departments within US pharmaceutical companies like <a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a> devoted to cost analysis. Regardless of the pricing strategy the common theme within all factors is to maximize profits.\n</p><p>This chart shows discrepancies in drug pricing in different countries, which indicates differences in both market conditions and government regulation. For instance, Canada has a drug ceiling price that drug prices cannot exceed.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (August 2016)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Marketing_expenses\">Marketing expenses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=3\" title=\"Edit section: Marketing expenses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A study has placed the amount spent on drug marketing at 2-19 times that on drug research.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Research_and_development\">Research and development</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=4\" title=\"Edit section: Research and development\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The table shows research and development statistics for pharmaceutical companies as of 2013 per Astra Zeneca.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\"><span title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (June 2016)\">page&#160;needed</span></a></i>&#93;</sup>\n</p>\n<table class=\"wikitable\">\n<tbody><tr>\n<th>Pharmaceutical company\n</th>\n<th>Number of drugs approved\n</th>\n<th>Average R&amp;D spending per drug (in $ Millions)\n</th>\n<th>Total R&amp;D spending from 1997-2011 (in $ Millions)\n</th></tr>\n<tr>\n<td><a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>\n</td>\n<td>5\n</td>\n<td>$11,790.93\n</td>\n<td>$58,955\n</td></tr>\n<tr>\n<td><a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a>\n</td>\n<td>10\n</td>\n<td>$8,170.81\n</td>\n<td>$81,708\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a>\n</td>\n<td>8\n</td>\n<td>$7,909.26\n</td>\n<td>$63,274\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Hoffmann-La_Roche\" title=\"Hoffmann-La Roche\">Roche Holding</a>\n</td>\n<td>11\n</td>\n<td>$7,803.77\n</td>\n<td>$85,841\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Pfizer\" title=\"Pfizer\">Pfizer</a>\n</td>\n<td>14\n</td>\n<td>$7,727.03\n</td>\n<td>$108,178\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Johnson_%26_Johnson\" title=\"Johnson &amp; Johnson\">Johnson &amp; Johnson</a>\n</td>\n<td>15\n</td>\n<td>$5,885.65\n</td>\n<td>$88,285\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Eli_Lilly_and_Company\" title=\"Eli Lilly and Company\">Eli Lilly &amp; Co.</a>\n</td>\n<td>11\n</td>\n<td>$4,577.04\n</td>\n<td>$50,347\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Abbott_Laboratories\" title=\"Abbott Laboratories\">Abbott Laboratories</a>\n</td>\n<td>8\n</td>\n<td>$4,496.21\n</td>\n<td>$35,970\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Merck_%26_Co.\" title=\"Merck &amp; Co.\">Merck &amp; Co Inc.</a>\n</td>\n<td>16\n</td>\n<td>$4,209.99\n</td>\n<td>$67,360\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Bristol-Myers_Squibb\" title=\"Bristol-Myers Squibb\">Bristol-Meyers Squibb Co.</a>\n</td>\n<td>11\n</td>\n<td>$4,152.26\n</td>\n<td>$45,675\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Novartis\" title=\"Novartis\">Novartis</a>\n</td>\n<td>21\n</td>\n<td>$3,983.13\n</td>\n<td>$83,646\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Amgen\" title=\"Amgen\">Amgen Inc.</a>\n</td>\n<td>9\n</td>\n<td>$3,692.14\n</td>\n<td>$33,229\n</td></tr></tbody></table>\n<p><a href=\"/wiki/Severin_Schwan\" title=\"Severin Schwan\">Severin Schwan</a>, the CEO of the Swiss company Roche, reported<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Dates_and_numbers#Chronological_items\" title=\"Wikipedia:Manual of Style/Dates and numbers\"><span title=\"The time period mentioned near this tag is ambiguous. (June 2016)\">when?</span></a></i>&#93;</sup> that Roche\u2019s research and development costs amounted to $8.4 billion, a quarter of the entire <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a> budget.<sup id=\"cite_ref-:1_4-2\" class=\"reference\"><a href=\"#cite_note-:1-4\">&#91;4&#93;</a></sup> Given the profit-driven nature of pharmaceutical companies and their research and development expenses, companies use their research and development expenses as a starting point to determine appropriate yet profitable prices.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup>\n</p><p>Pharmaceutical companies spend a large amount on research and development before a drug is released to the market and costs can be further divided into three major fields: the discovery into the drug\u2019s specific medical field, clinical trials, and failed drugs.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Discovery\">Discovery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=5\" title=\"Edit section: Discovery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p><a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">Drug discovery</a> is the area of research and development that amounts to the most amount of time and money.<sup class=\"noprint Inline-Template\" style=\"margin-left:0.1em; white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Words_to_watch#Unsupported_attributions\" title=\"Wikipedia:Manual of Style/Words to watch\"><span title=\"The material near this tag may use weasel words or too-vague attribution. (June 2016)\">according to whom?</span></a></i>&#93;</sup> The process can involve scientists to determine the germs, viruses, and bacteria that cause a specific disease or illness.<sup id=\"cite_ref-:2_8-0\" class=\"reference\"><a href=\"#cite_note-:2-8\">&#91;8&#93;</a></sup> The time frame can range from 3\u201320 years and costs can range between several million to tens of millions of dollars. Research teams attempt to break down disease components to find abnormal events/processes taking place in the body.<sup id=\"cite_ref-:2_8-1\" class=\"reference\"><a href=\"#cite_note-:2-8\">&#91;8&#93;</a></sup> Only then do scientists work on developing chemical compounds to treat these abnormalities with the aid of computer models.<sup id=\"cite_ref-:2_8-2\" class=\"reference\"><a href=\"#cite_note-:2-8\">&#91;8&#93;</a></sup>\n</p><p>After \"discovery\" and a creation of a chemical compound, pharmaceutical companies move forward with the Investigational New Drug (IND) Application from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">FDA</a>.<sup id=\"cite_ref-:2_8-3\" class=\"reference\"><a href=\"#cite_note-:2-8\">&#91;8&#93;</a></sup> After the investigation into the drug and given approval, pharmaceutical companies can move into pre-clinical trials and clinical trials.<sup id=\"cite_ref-:2_8-4\" class=\"reference\"><a href=\"#cite_note-:2-8\">&#91;8&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Trials\">Trials</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=6\" title=\"Edit section: Trials\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p><a href=\"/wiki/Drug_development\" title=\"Drug development\">Drug development</a> and pre-clinical trials focus on non-human subjects and work on animals such as rats. This is the most inexpensive phase of testing.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup>\n</p><p>The <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> mandates a 3 phase clinical trial testing that tests for side effects and the effectiveness of the drug with a single phase clinical trial costing upwards of $100 million.<sup id=\"cite_ref-:3_9-0\" class=\"reference\"><a href=\"#cite_note-:3-9\">&#91;9&#93;</a></sup>\n</p><p>After a drug has passed through all three phases, the pharmaceutical company can move forward with a New Drug Application from the FDA. In 2014, the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">FDA</a> charged between $1 million to $2 million for an NDA.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Failed_drugs\">Failed drugs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=7\" title=\"Edit section: Failed drugs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The processes of \"discovery\" and clinical trials amounts to approximately 12 years from research lab to the patient, in which about 10% of all drugs that start pre-clinical trials ever make it to actual human testing.<sup id=\"cite_ref-:2_8-5\" class=\"reference\"><a href=\"#cite_note-:2-8\">&#91;8&#93;</a></sup> Each pharmaceutical company (who have hundreds of drugs moving in and out of these phases) will never recuperate the costs of \"failed drugs\". Thus, profits made from one drug need to cover the costs of previous \"failed drugs\".\n</p>\n<h4><span class=\"mw-headline\" id=\"Relationship\">Relationship</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=8\" title=\"Edit section: Relationship\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Overall, research and development expenses relating to a pharmaceutical drug amount to the billions. For example, it was reported that <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a> spent upwards on average of $11 billion per drug for research and developmental purposes.<sup id=\"cite_ref-:3_9-1\" class=\"reference\"><a href=\"#cite_note-:3-9\">&#91;9&#93;</a></sup> The average of $11 billion only comprises the \"discovery\" costs, pre-clinical and clinical trial costs, and other expenses.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup> With the addition of \"failed drug\" costs, the $11 billion easily amounts to over $20 billion in expenses.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup> Therefore, an appropriate figure like $60 billion would be approximate sales figure that a pharmaceutical company like <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a> would aim to generate to cover these costs and make a profit at the same time.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup>\n</p><p>Total research and development costs provide pharmaceutical companies a ballpark estimation of total expenses. This is important in setting projected profit goals for a particular drug and thus, is one of the most necessary steps pharmaceutical companies take in pricing a particular drug.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Stakeholders\">Stakeholders</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=9\" title=\"Edit section: Stakeholders\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Patients and doctors can also have some input in pricing, though indirectly. Customers in the United States have been protesting the high prices for recent \"miracle\" drugs like <a href=\"/wiki/Daraprim\" class=\"mw-redirect\" title=\"Daraprim\">Daraprim</a> and <a href=\"/wiki/Harvoni\" class=\"mw-redirect\" title=\"Harvoni\">Harvoni</a>, both of which attempt to cure or treat major diseases (HIV/AIDS and <a href=\"/wiki/Hepatitis_C\" title=\"Hepatitis C\">hepatitis C</a>).<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> Public outcry has worked in many cases to control and even decide the pricing for some drugs. For example, there was severe backlash over Daraprim, a drug that treats toxoplasmosis.<sup id=\"cite_ref-:5_12-0\" class=\"reference\"><a href=\"#cite_note-:5-12\">&#91;12&#93;</a></sup> <a href=\"/wiki/Turing_Pharmaceuticals\" title=\"Turing Pharmaceuticals\">Turing Pharmaceuticals</a> under the leadership of <a href=\"/wiki/Martin_Shkreli\" title=\"Martin Shkreli\">Martin Shkreli</a> raised the price of the drug 5,500% from $13.50 to $750 per pill.<sup id=\"cite_ref-:5_12-1\" class=\"reference\"><a href=\"#cite_note-:5-12\">&#91;12&#93;</a></sup> After denouncement from 2016 presidential candidates <a href=\"/wiki/Hillary_Clinton\" title=\"Hillary Clinton\">Hillary Clinton</a> and <a href=\"/wiki/Bernie_Sanders\" title=\"Bernie Sanders\">Bernie Sanders</a>, Turing Pharmaceuticals decided to reduce the price.<sup id=\"cite_ref-:5_12-2\" class=\"reference\"><a href=\"#cite_note-:5-12\">&#91;12&#93;</a></sup>\n</p><p>With the recent trend of price gouging, legislators have introduced reform to curb these hikes, effectively controlling the pricing of drugs in the United States. Hillary Clinton announced a proposal to help patients with chronic and severe health conditions by placing a nationwide monthly cap of $250 on prescription out-of-pocket drugs.<sup id=\"cite_ref-:5_12-3\" class=\"reference\"><a href=\"#cite_note-:5-12\">&#91;12&#93;</a></sup>\n</p><p>Research for a drug that is curing something no one has ever cured before will cost much more than research for the medicine of a very common disease that has known treatments.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup> Also, there would be more patients for a more common ailment so that prices would be lower.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup> <a href=\"/wiki/Soliris\" class=\"mw-redirect\" title=\"Soliris\">Soliris</a> only treats two extremely rare diseases, so the number of consumers is low, making it an <a href=\"/wiki/Orphan_drug\" title=\"Orphan drug\">orphan drug</a>. Soliris still makes money because of its high price of over $400,000 per year per patient.<sup id=\"cite_ref-:1_4-3\" class=\"reference\"><a href=\"#cite_note-:1-4\">&#91;4&#93;</a></sup> The benefit of this drug is immense because it cures very rare diseases that would cost much more money to treat otherwise, which saves insurance companies and health agencies millions of dollars. Hence, insurance companies and health agencies are willing to pay these prices.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2016)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Public_policy\">Public policy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=10\" title=\"Edit section: Public policy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Policy makers in some countries have placed controls on the amount pharmaceutical companies can raise the price of drugs. In 2017, Democratic party leaders proposed the creation of a new federal agency to investigate and perhaps fine drug manufacturers who make unjustified price increases. Pharmaceutical companies would be required to submit a justification for a drug with a \u201csignificant price increase\u201d within at least 30 days of implementation. Under the terms of the proposal, Mylan\u2019s well-publicized price increase for its EpiPen product would fall below the criteria for a significant price increase, while the 5000% overnight increase of Turing Pharmaceuticals Daraprim (pyrimethamine) would be subject to regulatory action.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Effect_of_cost_on_consumers\">Effect of cost on consumers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=11\" title=\"Edit section: Effect of cost on consumers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>When the price of medicine goes up the <a href=\"/wiki/Quality_of_life\" title=\"Quality of life\">quality of life</a> of consumers who need the medicine decreases.<sup id=\"cite_ref-Skinner_2016_14-0\" class=\"reference\"><a href=\"#cite_note-Skinner_2016-14\">&#91;14&#93;</a></sup><sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> Consumers who have increased costs for medicine are more likely to change their lifestyle to spend less money on groceries, entertainment, and routine family needs.<sup id=\"cite_ref-Skinner_2016_14-1\" class=\"reference\"><a href=\"#cite_note-Skinner_2016-14\">&#91;14&#93;</a></sup> They are more likely to go into debt or postpone paying their existing debts.<sup id=\"cite_ref-Skinner_2016_14-2\" class=\"reference\"><a href=\"#cite_note-Skinner_2016-14\">&#91;14&#93;</a></sup> High drug prices can prevent people from saving for retirement.<sup id=\"cite_ref-Skinner_2016_14-3\" class=\"reference\"><a href=\"#cite_note-Skinner_2016-14\">&#91;14&#93;</a></sup> It is not uncommon for typical people to have challenges paying medical bills.<sup id=\"cite_ref-Skinner_2016_14-4\" class=\"reference\"><a href=\"#cite_note-Skinner_2016-14\">&#91;14&#93;</a></sup> Some people fail to get the medical care they need due to lack of money to pay for it.<sup id=\"cite_ref-Skinner_2016_14-5\" class=\"reference\"><a href=\"#cite_note-Skinner_2016-14\">&#91;14&#93;</a></sup>\n</p><p>Consumers respond to higher drug prices by doing what they can to save drug costs. The most commonly recommended course of action for consumers who seek to lower their drug costs is for them to tell their own doctor and pharmacist that they need to save money and then ask for advice.<sup id=\"cite_ref-Consumer_Reports_June_2016_16-0\" class=\"reference\"><a href=\"#cite_note-Consumer_Reports_June_2016-16\">&#91;16&#93;</a></sup> Doctors and pharmacists are professionals who know their fields and are the most likely source of information about options for reducing cost.<sup id=\"cite_ref-Consumer_Reports_June_2016_16-1\" class=\"reference\"><a href=\"#cite_note-Consumer_Reports_June_2016-16\">&#91;16&#93;</a></sup>\n</p><p>There can be significant variation of prices for drugs in different pharmacies, even within a single geographical area.<sup id=\"cite_ref-Consumer_Reports_January_2016_17-0\" class=\"reference\"><a href=\"#cite_note-Consumer_Reports_January_2016-17\">&#91;17&#93;</a></sup> Because of this, some people check prices at multiple pharmacies to seek lower prices.<sup id=\"cite_ref-Consumer_Reports_January_2016_17-1\" class=\"reference\"><a href=\"#cite_note-Consumer_Reports_January_2016-17\">&#91;17&#93;</a></sup> <a href=\"/wiki/Online_pharmacies\" class=\"mw-redirect\" title=\"Online pharmacies\">Online pharmacies</a> can offer low prices but many consumers using online services have experienced <a href=\"/wiki/Internet_fraud\" title=\"Internet fraud\">Internet fraud</a> and other problems.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>\n</p><p>Some consumers lower costs by asking their doctor for <a href=\"/wiki/Generic_drugs\" class=\"mw-redirect\" title=\"Generic drugs\">generic drugs</a> when available.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> Because pharmaceutical companies often set prices by pills rather than by dose, consumers can sometimes buy double-dose pills, <a href=\"/wiki/Pill_splitting\" title=\"Pill splitting\">split the pills</a> themselves with their doctor's permission, and save money in the process<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"By_region\">By region</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=12\" title=\"Edit section: By region\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"United_States\">United States</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=13\" title=\"Edit section: United States\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Prescription_drug_prices_in_the_United_States\" title=\"Prescription drug prices in the United States\">Prescription drug prices in the United States</a></div>\n<p>Prescription drug prices in the United States have been among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the new millennium, leading up to the <a href=\"/wiki/U.S._health_care_reform\" class=\"mw-redirect\" title=\"U.S. health care reform\">U.S. health care reform</a> debate of 2009, and received renewed attention in 2015. High prices have been attributed to monopolies given to manufacturers by the government and a lack of ability for organizations to negotiate prices.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"United_Kingdom\">United Kingdom</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=14\" title=\"Edit section: United Kingdom\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Most people in the countries of the <a href=\"/wiki/United_Kingdom\" title=\"United Kingdom\">United Kingdom</a> get prescriptions partly or totally paid for by the <a href=\"/wiki/National_Health_Service\" title=\"National Health Service\">National Health Service</a>.\n</p>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Prescription_charges\" title=\"Prescription charges\">Prescription charges</a></div>\n<h3><span class=\"mw-headline\" id=\"Developing_world\">Developing world</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=15\" title=\"Edit section: Developing world\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In many <a href=\"/wiki/Developing_countries\" class=\"mw-redirect\" title=\"Developing countries\">developing countries</a><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Avoid_weasel_words\" class=\"mw-redirect\" title=\"Wikipedia:Avoid weasel words\"><span title=\"The material near this tag possibly uses too vague attribution or weasel words. (March 2017)\">which?</span></a></i>&#93;</sup> the cost of proprietary drugs is beyond the reach of the majority of the population.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> There have been attempts both by international agreements and by <a href=\"/wiki/Pharmaceutical_company\" class=\"mw-redirect\" title=\"Pharmaceutical company\">pharmaceutical companies</a> to provide drugs at low cost, either supplied by manufacturers who own the drugs,<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> or manufactured locally as <a href=\"/wiki/Generic_drug\" title=\"Generic drug\">generic versions of drugs</a> which are elsewhere protected by <a href=\"/wiki/Patent\" title=\"Patent\">patent</a>.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> Countries without manufacturing capability may import such generics.\n</p><p>The legal framework regarding generic versions of patented drugs is formalised in the <a href=\"/wiki/Doha_Declaration\" title=\"Doha Declaration\">Doha Declaration</a> on <a href=\"/wiki/Trade-Related_Aspects_of_Intellectual_Property_Rights\" class=\"mw-redirect\" title=\"Trade-Related Aspects of Intellectual Property Rights\">Trade-Related Aspects of Intellectual Property Rights</a> and later agreements.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup>\n</p><p>People and governments in developing countries have far fewer financial resources to bear high monopoly prices and drug prices even for patent-protected medicines in these countries are often considerably lower.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup> Profits are often insubstantial and do not proportionally cover development costs.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup> In many cases, a patent holder will license generic manufacturers to sell to low-income countries at low cost.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup> India has less restrictive patent regimes which make the manufacture of generic medications possible sooner, for sale domestically or in other countries where the patent protections do not apply.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup> Typically the cost of making small-molecule drugs is only a very small portion of a developed-country market monopoly price, which makes generic manufacturing very cheap.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup> In contrast, some drugs are inherently expensive to produce, such as the <a href=\"/wiki/Biopharmaceutical\" title=\"Biopharmaceutical\">biopharmaceutical</a> drug <a href=\"/wiki/Cerezyme\" class=\"mw-redirect\" title=\"Cerezyme\">Cerezyme</a>, typically costing $200,000 per year in the United States.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2017)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=16\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Generic_drug\" title=\"Generic drug\">Generic drug</a></li>\n<li><a href=\"/wiki/Inverse_benefit_law\" title=\"Inverse benefit law\">Inverse benefit law</a></li>\n<li><a href=\"/wiki/Pill_splitting\" title=\"Pill splitting\">Pill splitting</a></li>\n<li><a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\">Prescription drug</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=17\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-NYT-20151219-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NYT-20151219_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">The Editorial Board (19 December 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2015/12/20/opinion/sunday/no-justification-for-high-drug-prices.html\">\"No Justification for High Drug Prices\"</a>. <i><a href=\"/wiki/New_York_Times\" class=\"mw-redirect\" title=\"New York Times\">New York Times</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 December</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=No+Justification+for+High+Drug+Prices&amp;rft.date=2015-12-19&amp;rft.au=The+Editorial+Board&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2015%2F12%2F20%2Fopinion%2Fsunday%2Fno-justification-for-high-drug-prices.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wirtz, VJ; Hogerzeil, HV; Gray, AL; Bigdeli;  et al. (28 January 2017). \"Essential medicines for universal health coverage\". <i>Lancet</i>. <b>389</b> (10067): 403\u2013476. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2816%2931599-9\">10.1016/S0140-6736(16)31599-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27832874\">27832874</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Essential+medicines+for+universal+health+coverage.&amp;rft.volume=389&amp;rft.issue=10067&amp;rft.pages=403-476&amp;rft.date=2017-01-28&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2816%2931599-9&amp;rft_id=info%3Apmid%2F27832874&amp;rft.aulast=Wirtz&amp;rft.aufirst=VJ&amp;rft.au=Hogerzeil%2C+HV&amp;rft.au=Gray%2C+AL&amp;rft.au=Bigdeli&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Explicit use of et al. (<a href=\"/wiki/Category:CS1_maint:_Explicit_use_of_et_al.\" title=\"Category:CS1 maint: Explicit use of et al.\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://static1.squarespace.com/static/518a3cfee4b0a77d03a62c98/t/534fc9ebe4b05a88e5fbab70/1397737963288/2013+iFHP+FINAL+4+14+14.pdf\">International Federation of Health Plans.</a></span>\n</li>\n<li id=\"cite_note-:1-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:1_4-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:1_4-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">LaMattina, John. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.forbes.com/sites/johnlamattina/2012/09/10/on-the-pricing-of-new-drugs/#7257eeb14b8e\">\"What Is The Rationale For The Pricing Of New Drugs?\"</a>. <i>Forbes</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-03-15</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=What+Is+The+Rationale+For+The+Pricing+Of+New+Drugs%3F&amp;rft.aulast=LaMattina&amp;rft.aufirst=John&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fjohnlamattina%2F2012%2F09%2F10%2Fon-the-pricing-of-new-drugs%2F%237257eeb14b8e&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.huffingtonpost.com/2012/08/09/pharmaceutical-companies-marketing_n_1760380.html\">Pharmaceutical Companies Spent 19 Times More On Self-Promotion Than Basic Research: Report</a> The Huffington Post, 2012</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Al-Huniti, Nidal (June 20, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.phuse.eu/download.aspx?type=cms&amp;docID=5334\">\"Quantitative Decision-Makingin Drug Development\"</a>. AstraZeneca. p.&#160;23<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 13,</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Quantitative+Decision-Makingin+Drug+Development&amp;rft.pages=23&amp;rft.pub=AstraZeneca&amp;rft.date=2013-06-20&amp;rft.aulast=Al-Huniti&amp;rft.aufirst=Nidal&amp;rft_id=http%3A%2F%2Fwww.phuse.eu%2Fdownload.aspx%3Ftype%3Dcms%26docID%3D5334&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Klotz, Lynn (January 16, 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.genengnews.com/keywordsandtools/print/3/33641/\">\"What Is the Real Drug Development Cost for Very Small Biotech Companies?\"</a>. <i>Genetic Engineering &amp; Biotechnology News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 15,</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=What+Is+the+Real+Drug+Development+Cost+for+Very+Small+Biotech+Companies%3F&amp;rft.date=2014-01-16&amp;rft.aulast=Klotz&amp;rft.aufirst=Lynn&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fkeywordsandtools%2Fprint%2F3%2F33641%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:2_8-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:2_8-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:2_8-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:2_8-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ca-biomed.org/pdf/media-kit/fact-sheets/CBRADrugDevelop.pdf\">\"New Drug Development Process\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>California Biomedical Research Association</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 15,</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=California+Biomedical+Research+Association&amp;rft.atitle=New+Drug+Development+Process&amp;rft_id=http%3A%2F%2Fwww.ca-biomed.org%2Fpdf%2Fmedia-kit%2Ffact-sheets%2FCBRADrugDevelop.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:3-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:3_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:3_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Herper, Matthew. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/#19426c5b4477\">\"The Truly Staggering Cost Of Inventing New Drugs\"</a>. <i>Forbes</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-03-15</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=The+Truly+Staggering+Cost+Of+Inventing+New+Drugs&amp;rft.aulast=Herper&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F02%2F10%2Fthe-truly-staggering-cost-of-inventing-new-drugs%2F%2319426c5b4477&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Gaffney, Alexander. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.raps.org/focus-online/news/news-article-view/article/3876/\">\"FDA Publishes All User Fee Rates for Fiscal Year 2014 | RAPS\"</a>. <i>www.raps.org</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-03-15</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.raps.org&amp;rft.atitle=FDA+Publishes+All+User+Fee+Rates+for+Fiscal+Year+2014+%7C+RAPS&amp;rft.aulast=Gaffney&amp;rft.aufirst=Alexander&amp;rft_id=http%3A%2F%2Fwww.raps.org%2Ffocus-online%2Fnews%2Fnews-article-view%2Farticle%2F3876%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Sanghoee, Sanjay. <a rel=\"nofollow\" class=\"external text\" href=\"http://time.com/3731359/the-unintended-side-effect-of-lower-drug-prices/\">\"The Unintended Side Effect of Lower Drug Prices\"</a>. <i>TIME.com</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 15,</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=TIME.com&amp;rft.atitle=The+Unintended+Side+Effect+of+Lower+Drug+Prices&amp;rft.aulast=Sanghoee&amp;rft.aufirst=Sanjay&amp;rft_id=http%3A%2F%2Ftime.com%2F3731359%2Fthe-unintended-side-effect-of-lower-drug-prices%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:5-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:5_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:5_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:5_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:5_12-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cbc.ca/news/health/turing-clinton-prescription-drugs-1.3238202\">\"CEO says he'll lower price of drug after public outcry over 5,000% price hike\"</a>. <i>www.CBC.ca</i>. September 23, 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 16,</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.CBC.ca&amp;rft.atitle=CEO+says+he%27ll+lower+price+of+drug+after+public+outcry+over+5%2C000%25+price+hike&amp;rft.date=2015-09-23&amp;rft_id=http%3A%2F%2Fwww.cbc.ca%2Fnews%2Fhealth%2Fturing-clinton-prescription-drugs-1.3238202&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Gingery, Derrick (24 July 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://pink.pharmamedtechbi.com/PS121171/Dems-Better-Deal-Would-Create-Drug-Price-Gouging-Enforcer\">\"Dems' 'Better Deal' Would Create Drug Price Gouging 'Enforcer<span style=\"padding-right:0.2em;\">'</span>\"</a>. <a href=\"/wiki/OTC_Markets_Group\" title=\"OTC Markets Group\">OTC Markets Group</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">27 July</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dems%27+%27Better+Deal%27+Would+Create+Drug+Price+Gouging+%27Enforcer%27&amp;rft.date=2017-07-24&amp;rft.aulast=Gingery&amp;rft.aufirst=Derrick&amp;rft_id=https%3A%2F%2Fpink.pharmamedtechbi.com%2FPS121171%2FDems-Better-Deal-Would-Create-Drug-Price-Gouging-Enforcer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Skinner_2016-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Skinner_2016_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Skinner_2016_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Skinner_2016_14-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Skinner_2016_14-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Skinner_2016_14-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Skinner_2016_14-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Skinner, Ginger (21 June 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.consumerreports.org/drugs/as-drug-prices-increase-quality-of-life-goes-down/\">\"As Drug Prices Increase, Quality of Life Goes Down\"</a>. <i>Consumer Reports</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Consumer+Reports&amp;rft.atitle=As+Drug+Prices+Increase%2C+Quality+of+Life+Goes+Down&amp;rft.date=2016-06-21&amp;rft.aulast=Skinner&amp;rft.aufirst=Ginger&amp;rft_id=http%3A%2F%2Fwww.consumerreports.org%2Fdrugs%2Fas-drug-prices-increase-quality-of-life-goes-down%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Walker, Joseph (31 December 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/patients-struggle-with-high-drug-prices-1451557981\">\"Patients Struggle With High Drug Prices\"</a>. <i>Wall Street Journal</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Patients+Struggle+With+High+Drug+Prices&amp;rft.date=2015-12-31&amp;rft.aulast=Walker&amp;rft.aufirst=Joseph&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpatients-struggle-with-high-drug-prices-1451557981&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Consumer_Reports_June_2016-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Consumer_Reports_June_2016_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Consumer_Reports_June_2016_16-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Consumer Reports (21 June 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.youtube.com/watch?v=OXyrXS6_b-k\">\"The Way To Save On Your Prescription Drugs: Speak Up\"</a>. <i>www.consumerreports.org</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.consumerreports.org&amp;rft.atitle=The+Way+To+Save+On+Your+Prescription+Drugs%3A+Speak+Up&amp;rft.date=2016-06-21&amp;rft.au=Consumer+Reports&amp;rft_id=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DOXyrXS6_b-k&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Consumer_Reports_January_2016-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Consumer_Reports_January_2016_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Consumer_Reports_January_2016_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Consumer Reports (5 January 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.consumerreports.org/drugs/6-tips-for-finding-the-best-prescription-drug-prices/\">\"Save Money on Meds: 6 Tips for Finding the Best Prescription Drug Prices\"</a>. <i>Consumer Reports</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Consumer+Reports&amp;rft.atitle=Save+Money+on+Meds%3A+6+Tips+for+Finding+the+Best+Prescription+Drug+Prices&amp;rft.date=2016-01-05&amp;rft.au=Consumer+Reports&amp;rft_id=http%3A%2F%2Fwww.consumerreports.org%2Fdrugs%2F6-tips-for-finding-the-best-prescription-drug-prices%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Consumer Reports (30 August 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.consumerreports.org/cro/news/2015/08/is-it-ok-to-buy-medicine-online/index.htm\">\"Is it OK to buy medicine online? - Consumer Reports\"</a>. <i>Consumer Reports</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Consumer+Reports&amp;rft.atitle=Is+it+OK+to+buy+medicine+online%3F+-+Consumer+Reports&amp;rft.date=2015-08-30&amp;rft.au=Consumer+Reports&amp;rft_id=http%3A%2F%2Fwww.consumerreports.org%2Fcro%2Fnews%2F2015%2F08%2Fis-it-ok-to-buy-medicine-online%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Consumer Reports (January 2012). <a rel=\"nofollow\" class=\"external text\" href=\"http://consumerhealthchoices.org/wp-content/uploads/2012/01/GenericDrugs-FINAL.pdf\">\"Generic Drugs: The Same Medicine for Less Money\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Consumer Reports</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Consumer+Reports&amp;rft.atitle=Generic+Drugs%3A+The+Same+Medicine+for+Less+Money&amp;rft.date=2012-01&amp;rft.au=Consumer+Reports&amp;rft_id=http%3A%2F%2Fconsumerhealthchoices.org%2Fwp-content%2Fuploads%2F2012%2F01%2FGenericDrugs-FINAL.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Consumer Reports (30 December 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.consumerreports.org/drugs/is-it-safe-to-split-pills-in-half/\">\"When It's Safe to Split Pills\"</a>. <i>Consumer Reports</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 March</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Consumer+Reports&amp;rft.atitle=When+It%27s+Safe+to+Split+Pills&amp;rft.date=2015-12-30&amp;rft.au=Consumer+Reports&amp;rft_id=http%3A%2F%2Fwww.consumerreports.org%2Fdrugs%2Fis-it-safe-to-split-pills-in-half%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kesselheim, Aaron S.; Avorn, Jerry; Sarpatwari, Ameet (23 August 2016). \"The High Cost of Prescription Drugs in the United States\". <i>JAMA</i>. <b>316</b> (8): 858. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2016.11237\">10.1001/jama.2016.11237</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=The+High+Cost+of+Prescription+Drugs+in+the+United+States&amp;rft.volume=316&amp;rft.issue=8&amp;rft.pages=858&amp;rft.date=2016-08-23&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2016.11237&amp;rft.aulast=Kesselheim&amp;rft.aufirst=Aaron+S.&amp;rft.au=Avorn%2C+Jerry&amp;rft.au=Sarpatwari%2C+Ameet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\">Angela Saini <a rel=\"nofollow\" class=\"external text\" href=\"https://www.newscientist.com/channel/health/mg19325972.800-making-poor-nations-pay-for-drugs.html\">Making poor nations pay for drugs</a>, New Scientist, 31 March 2007</span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.newscientist.com/channel/health/dn14141-gsk-tops-new-ethical-ranking-for-investors.html\">GSK tops new ethical ranking for investors \u2013 health \u2013 16 June 2008</a>. New Scientist. Retrieved on 23 April 2011.</span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.newscientist.com/article/dn870-drugs-bust.html\">Drugs bust \u2013 13 June 2001</a>. New Scientist. Retrieved on 23 April 2011.</span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_information\">Further information</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prescription_costs&amp;action=edit&amp;section=18\" title=\"Edit section: Further information\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><cite class=\"citation journal\">Alexander, G. C.; Casalino, LP; Meltzer, DO (2005). \"Physician Strategies to Reduce Patients' Out-of-pocket Prescription Costs\". <i>Archives of Internal Medicine</i>. <b>165</b> (6): 633\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archinte.165.6.633\">10.1001/archinte.165.6.633</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15795338\">15795338</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.atitle=Physician+Strategies+to+Reduce+Patients%27+Out-of-pocket+Prescription+Costs&amp;rft.volume=165&amp;rft.issue=6&amp;rft.pages=633-6&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.165.6.633&amp;rft_id=info%3Apmid%2F15795338&amp;rft.aulast=Alexander&amp;rft.aufirst=G.+C.&amp;rft.au=Casalino%2C+LP&amp;rft.au=Meltzer%2C+DO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Alexander, G C.; Tseng, C.-W. (2004). \"Six strategies to identify and assist patients burdened by out-of-pocket prescription costs\". <i>Cleveland Clinic Journal of Medicine</i>. <b>71</b> (5): 433\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3949/ccjm.71.5.433\">10.3949/ccjm.71.5.433</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15195778\">15195778</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cleveland+Clinic+Journal+of+Medicine&amp;rft.atitle=Six+strategies+to+identify+and+assist+patients+burdened+by+out-of-pocket+prescription+costs&amp;rft.volume=71&amp;rft.issue=5&amp;rft.pages=433-7&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.3949%2Fccjm.71.5.433&amp;rft_id=info%3Apmid%2F15195778&amp;rft.aulast=Alexander&amp;rft.aufirst=G+C.&amp;rft.au=Tseng%2C+C.-W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Alexander, G. Caleb; Casalino, Lawrence P.; Tseng, Chien-Wen; McFadden, Diane; Meltzer, David O. (2004). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1492500\">\"Barriers to Patient-physician Communication About Out-of-pocket Costs\"</a>. <i>Journal of General Internal Medicine</i>. <b>19</b> (8): 856\u201360. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1525-1497.2004.30249.x\">10.1111/j.1525-1497.2004.30249.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1492500\">1492500</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15242471\">15242471</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+General+Internal+Medicine&amp;rft.atitle=Barriers+to+Patient-physician+Communication+About+Out-of-pocket+Costs&amp;rft.volume=19&amp;rft.issue=8&amp;rft.pages=856-60&amp;rft.date=2004&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1492500&amp;rft_id=info%3Apmid%2F15242471&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1525-1497.2004.30249.x&amp;rft.aulast=Alexander&amp;rft.aufirst=G.+Caleb&amp;rft.au=Casalino%2C+Lawrence+P.&amp;rft.au=Tseng%2C+Chien-Wen&amp;rft.au=McFadden%2C+Diane&amp;rft.au=Meltzer%2C+David+O.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1492500&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Pham, H. H.; Alexander, G. C.; O'Malley, A. S. (2007). \"Physician Consideration of Patients' Out-of-Pocket Costs in Making Common Clinical Decisions\". <i>Archives of Internal Medicine</i>. <b>167</b> (7): 663\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archinte.167.7.663\">10.1001/archinte.167.7.663</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17420424\">17420424</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.atitle=Physician+Consideration+of+Patients%27+Out-of-Pocket+Costs+in+Making+Common+Clinical+Decisions&amp;rft.volume=167&amp;rft.issue=7&amp;rft.pages=663-8&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.167.7.663&amp;rft_id=info%3Apmid%2F17420424&amp;rft.aulast=Pham&amp;rft.aufirst=H.+H.&amp;rft.au=Alexander%2C+G.+C.&amp;rft.au=O%27Malley%2C+A.+S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Rabbani, Atonu; Alexander, G. Caleb (2008). \"Out-of-pocket and Total Costs of Fixed-dose Combination Antihypertensives and Their Components\". <i>American Journal of Hypertension</i>. <b>21</b> (5): 509\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ajh.2008.31\">10.1038/ajh.2008.31</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18437141\">18437141</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Hypertension&amp;rft.atitle=Out-of-pocket+and+Total+Costs+of+Fixed-dose+Combination+Antihypertensives+and+Their+Components&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=509-13&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1038%2Fajh.2008.31&amp;rft_id=info%3Apmid%2F18437141&amp;rft.aulast=Rabbani&amp;rft.aufirst=Atonu&amp;rft.au=Alexander%2C+G.+Caleb&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APrescription+costs\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2257\nCached time: 20180915040929\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.532 seconds\nReal time usage: 0.598 seconds\nPreprocessor visited node count: 4199/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 87113/2097152 bytes\nTemplate argument size: 11338/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 8/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 27136/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.290/10.000 seconds\nLua memory usage: 4.71 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  511.251      1 -total\n 40.60%  207.555     22 Template:Fix\n 39.17%  200.248     19 Template:Citation_needed\n 28.50%  145.697      1 Template:Reflist\n 20.05%  102.528     22 Template:Delink\n 18.40%   94.064     44 Template:Category_handler\n 11.00%   56.235     14 Template:Cite_web\n  8.53%   43.613      7 Template:Cite_journal\n  8.44%   43.139      3 Template:Cite_news\n  7.12%   36.409      1 Template:Use_dmy_dates\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:18665076-0!canonical and timestamp 20180915040928 and revision id 854436323\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Explicit_use_of_et_al."},{"sortkey":"Prescription Costs","hidden":"","*":"Use_dmy_dates_from_January_2015"},{"sortkey":"Prescription Costs","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"Prescription Costs","hidden":"","*":"Articles_with_unsourced_statements_from_March_2017"},{"sortkey":"Prescription Costs","hidden":"","*":"Articles_with_unsourced_statements_from_August_2016"},{"sortkey":"Prescription Costs","hidden":"","*":"Wikipedia_articles_needing_page_number_citations_from_June_2016"},{"sortkey":"Prescription Costs","hidden":"","*":"All_articles_with_vague_or_ambiguous_time"},{"sortkey":"Prescription Costs","hidden":"","*":"Vague_or_ambiguous_time_from_June_2016"},{"sortkey":"Prescription Costs","hidden":"","*":"Articles_with_unsourced_statements_from_June_2016"},{"sortkey":"Prescription Costs","hidden":"","*":"All_articles_with_specifically_marked_weasel-worded_phrases"},{"sortkey":"Prescription Costs","hidden":"","*":"Articles_with_specifically_marked_weasel-worded_phrases_from_June_2016"},{"sortkey":"Prescription Costs","hidden":"","*":"Articles_with_specifically_marked_weasel-worded_phrases_from_March_2017"},{"sortkey":"Prescription Costs","*":"Pharmaceutical_industry"},{"sortkey":"Prescription Costs","*":"Pharmacy"},{"sortkey":"Prescription Costs","*":"Drug_pricing"}],"links":[{"ns":14,"exists":"","*":"Category:Use dmy dates from January 2015"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from March 2017"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from August 2016"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing page number citations from June 2016"},{"ns":14,"exists":"","*":"Category:Vague or ambiguous time from June 2016"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from June 2016"},{"ns":14,"exists":"","*":"Category:Articles with specifically marked weasel-worded phrases from June 2016"},{"ns":14,"exists":"","*":"Category:Articles with specifically marked weasel-worded phrases from March 2017"},{"ns":14,"exists":"","*":"Category:CS1 maint: Explicit use of et al."},{"ns":0,"exists":"","*":"Abbott Laboratories"},{"ns":0,"exists":"","*":"Amgen"},{"ns":0,"exists":"","*":"AstraZeneca"},{"ns":0,"exists":"","*":"Bernie Sanders"},{"ns":0,"exists":"","*":"Biopharmaceutical"},{"ns":0,"exists":"","*":"Bristol-Myers Squibb"},{"ns":0,"exists":"","*":"Celebrex"},{"ns":0,"exists":"","*":"Cerezyme"},{"ns":0,"exists":"","*":"Copaxone"},{"ns":0,"exists":"","*":"Cymbalta"},{"ns":0,"exists":"","*":"Daraprim"},{"ns":0,"exists":"","*":"Developing countries"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Doha Declaration"},{"ns":0,"exists":"","*":"Drug development"},{"ns":0,"exists":"","*":"Drug discovery"},{"ns":0,"exists":"","*":"Eli Lilly and Company"},{"ns":0,"exists":"","*":"Enbrel"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Generic drug"},{"ns":0,"exists":"","*":"Generic drugs"},{"ns":0,"exists":"","*":"GlaxoSmithKline"},{"ns":0,"exists":"","*":"Harvoni"},{"ns":0,"exists":"","*":"Health care cost"},{"ns":0,"exists":"","*":"Hepatitis C"},{"ns":0,"exists":"","*":"Hillary Clinton"},{"ns":0,"exists":"","*":"Hoffmann-La Roche"},{"ns":0,"exists":"","*":"Humira"},{"ns":0,"exists":"","*":"Internet fraud"},{"ns":0,"exists":"","*":"Inverse benefit law"},{"ns":0,"exists":"","*":"Johnson & Johnson"},{"ns":0,"exists":"","*":"Martin Shkreli"},{"ns":0,"exists":"","*":"Merck & Co."},{"ns":0,"exists":"","*":"National Health Service"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"New York Times"},{"ns":0,"exists":"","*":"Nexium"},{"ns":0,"exists":"","*":"Novartis"},{"ns":0,"exists":"","*":"OTC Markets Group"},{"ns":0,"exists":"","*":"Online pharmacies"},{"ns":0,"exists":"","*":"Orphan drug"},{"ns":0,"exists":"","*":"Patent"},{"ns":0,"exists":"","*":"Pfizer"},{"ns":0,"exists":"","*":"Pharmaceutical company"},{"ns":0,"exists":"","*":"Pill splitting"},{"ns":0,"exists":"","*":"Prescription charges"},{"ns":0,"exists":"","*":"Prescription drug"},{"ns":0,"exists":"","*":"Prescription drug prices in the United States"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Quality of life"},{"ns":0,"exists":"","*":"Sanofi"},{"ns":0,"exists":"","*":"Severin Schwan"},{"ns":0,"exists":"","*":"Soliris"},{"ns":0,"exists":"","*":"Trade-Related Aspects of Intellectual Property Rights"},{"ns":0,"exists":"","*":"Turing Pharmaceuticals"},{"ns":0,"exists":"","*":"U.S. health care reform"},{"ns":0,"exists":"","*":"United Kingdom"},{"ns":4,"exists":"","*":"Wikipedia:Avoid weasel words"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Manual of Style/Dates and numbers"},{"ns":4,"exists":"","*":"Wikipedia:Manual of Style/Words to watch"}],"templates":[{"ns":10,"exists":"","*":"Template:Use dmy dates"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Rp"},{"ns":10,"exists":"","*":"Template:Page needed"},{"ns":10,"exists":"","*":"Template:When"},{"ns":10,"exists":"","*":"Template:According to whom"},{"ns":10,"exists":"","*":"Template:Fix-span"},{"ns":10,"exists":"","*":"Template:Replace"},{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Which"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["https://www.nytimes.com/2015/12/20/opinion/sunday/no-justification-for-high-drug-prices.html","//doi.org/10.1016/S0140-6736(16)31599-9","//www.ncbi.nlm.nih.gov/pubmed/27832874","https://static1.squarespace.com/static/518a3cfee4b0a77d03a62c98/t/534fc9ebe4b05a88e5fbab70/1397737963288/2013+iFHP+FINAL+4+14+14.pdf","https://www.forbes.com/sites/johnlamattina/2012/09/10/on-the-pricing-of-new-drugs/#7257eeb14b8e","http://www.huffingtonpost.com/2012/08/09/pharmaceutical-companies-marketing_n_1760380.html","http://www.phuse.eu/download.aspx?type=cms&docID=5334","http://www.genengnews.com/keywordsandtools/print/3/33641/","http://www.ca-biomed.org/pdf/media-kit/fact-sheets/CBRADrugDevelop.pdf","https://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/#19426c5b4477","http://www.raps.org/focus-online/news/news-article-view/article/3876/","http://time.com/3731359/the-unintended-side-effect-of-lower-drug-prices/","http://www.cbc.ca/news/health/turing-clinton-prescription-drugs-1.3238202","https://pink.pharmamedtechbi.com/PS121171/Dems-Better-Deal-Would-Create-Drug-Price-Gouging-Enforcer","http://www.consumerreports.org/drugs/as-drug-prices-increase-quality-of-life-goes-down/","https://www.wsj.com/articles/patients-struggle-with-high-drug-prices-1451557981","https://www.youtube.com/watch?v=OXyrXS6_b-k","http://www.consumerreports.org/drugs/6-tips-for-finding-the-best-prescription-drug-prices/","http://www.consumerreports.org/cro/news/2015/08/is-it-ok-to-buy-medicine-online/index.htm","http://consumerhealthchoices.org/wp-content/uploads/2012/01/GenericDrugs-FINAL.pdf","http://www.consumerreports.org/drugs/is-it-safe-to-split-pills-in-half/","//doi.org/10.1001/jama.2016.11237","https://www.newscientist.com/channel/health/mg19325972.800-making-poor-nations-pay-for-drugs.html","https://www.newscientist.com/channel/health/dn14141-gsk-tops-new-ethical-ranking-for-investors.html","https://www.newscientist.com/article/dn870-drugs-bust.html","//doi.org/10.1001/archinte.165.6.633","//www.ncbi.nlm.nih.gov/pubmed/15795338","//doi.org/10.3949/ccjm.71.5.433","//www.ncbi.nlm.nih.gov/pubmed/15195778","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1492500","//doi.org/10.1111/j.1525-1497.2004.30249.x","//www.ncbi.nlm.nih.gov/pubmed/15242471","//doi.org/10.1001/archinte.167.7.663","//www.ncbi.nlm.nih.gov/pubmed/17420424","//doi.org/10.1038/ajh.2008.31","//www.ncbi.nlm.nih.gov/pubmed/18437141"],"sections":[{"toclevel":1,"level":"2","line":"Definition","number":"1","index":"1","fromtitle":"Prescription_costs","byteoffset":163,"anchor":"Definition"},{"toclevel":1,"level":"2","line":"Drug pricing factors","number":"2","index":"2","fromtitle":"Prescription_costs","byteoffset":1494,"anchor":"Drug_pricing_factors"},{"toclevel":2,"level":"3","line":"Marketing expenses","number":"2.1","index":"3","fromtitle":"Prescription_costs","byteoffset":3381,"anchor":"Marketing_expenses"},{"toclevel":2,"level":"3","line":"Research and development","number":"2.2","index":"4","fromtitle":"Prescription_costs","byteoffset":3720,"anchor":"Research_and_development"},{"toclevel":3,"level":"4","line":"Discovery","number":"2.2.1","index":"5","fromtitle":"Prescription_costs","byteoffset":5997,"anchor":"Discovery"},{"toclevel":3,"level":"4","line":"Trials","number":"2.2.2","index":"6","fromtitle":"Prescription_costs","byteoffset":7283,"anchor":"Trials"},{"toclevel":3,"level":"4","line":"Failed drugs","number":"2.2.3","index":"7","fromtitle":"Prescription_costs","byteoffset":8453,"anchor":"Failed_drugs"},{"toclevel":3,"level":"4","line":"Relationship","number":"2.2.4","index":"8","fromtitle":"Prescription_costs","byteoffset":8939,"anchor":"Relationship"},{"toclevel":2,"level":"3","line":"Stakeholders","number":"2.3","index":"9","fromtitle":"Prescription_costs","byteoffset":10092,"anchor":"Stakeholders"},{"toclevel":2,"level":"3","line":"Public policy","number":"2.4","index":"10","fromtitle":"Prescription_costs","byteoffset":12629,"anchor":"Public_policy"},{"toclevel":1,"level":"2","line":"Effect of cost on consumers","number":"3","index":"11","fromtitle":"Prescription_costs","byteoffset":13684,"anchor":"Effect_of_cost_on_consumers"},{"toclevel":1,"level":"2","line":"By region","number":"4","index":"12","fromtitle":"Prescription_costs","byteoffset":17507,"anchor":"By_region"},{"toclevel":2,"level":"3","line":"United States","number":"4.1","index":"13","fromtitle":"Prescription_costs","byteoffset":17521,"anchor":"United_States"},{"toclevel":2,"level":"3","line":"United Kingdom","number":"4.2","index":"14","fromtitle":"Prescription_costs","byteoffset":18298,"anchor":"United_Kingdom"},{"toclevel":2,"level":"3","line":"Developing world","number":"4.3","index":"15","fromtitle":"Prescription_costs","byteoffset":18486,"anchor":"Developing_world"},{"toclevel":1,"level":"2","line":"See also","number":"5","index":"16","fromtitle":"Prescription_costs","byteoffset":20970,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"17","fromtitle":"Prescription_costs","byteoffset":21076,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further information","number":"7","index":"18","fromtitle":"Prescription_costs","byteoffset":21109,"anchor":"Further_information"}],"parsewarnings":[],"displaytitle":"Prescription costs","iwlinks":[],"properties":[{"name":"defaultsort","*":"Prescription Costs"},{"name":"wikibase_item","*":"Q7240896"}]}}